Published in Hospital Law Weekly, June 26th, 2008
"To assess the role of Tc-depreotide in patients with negative or weakly positive OctreoScan (Krenning score <or=1; measured on a scale range 0-4). To determine the usefulness of Tc-depreotide scintigraphy for highlighting...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.